Exagen Statistics
Total Valuation
Exagen has a market cap or net worth of $107.39 million. The enterprise value is $122.62 million.
Important Dates
The last earnings date was Monday, May 5, 2025, before market open.
| Earnings Date | May 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Exagen has 17.90 million shares outstanding. The number of shares has increased by 3.22% in one year.
| Current Share Class | 17.90M |
| Shares Outstanding | 17.90M |
| Shares Change (YoY) | +3.22% |
| Shares Change (QoQ) | +0.70% |
| Owned by Insiders (%) | 10.83% |
| Owned by Institutions (%) | 30.42% |
| Float | 9.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.99 |
| Forward PS | 1.65 |
| PB Ratio | 17.27 |
| P/TBV Ratio | 17.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.16 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.32, with a Debt / Equity ratio of 3.68.
| Current Ratio | 2.32 |
| Quick Ratio | 1.85 |
| Debt / Equity | 3.68 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.28 |
Financial Efficiency
Return on equity (ROE) is -117.50% and return on invested capital (ROIC) is -23.74%.
| Return on Equity (ROE) | -117.50% |
| Return on Assets (ROA) | -19.21% |
| Return on Invested Capital (ROIC) | -23.74% |
| Return on Capital Employed (ROCE) | -53.23% |
| Revenue Per Employee | $263,833 |
| Profits Per Employee | -$72,126 |
| Employee Count | 215 |
| Asset Turnover | 1.25 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Exagen has paid $12,000 in taxes.
| Income Tax | 12,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +352.94% in the last 52 weeks. The beta is 1.51, so Exagen's price volatility has been higher than the market average.
| Beta (5Y) | 1.51 |
| 52-Week Price Change | +352.94% |
| 50-Day Moving Average | 4.43 |
| 200-Day Moving Average | 3.67 |
| Relative Strength Index (RSI) | 59.70 |
| Average Volume (20 Days) | 284,519 |
Short Selling Information
The latest short interest is 60,835, so 0.34% of the outstanding shares have been sold short.
| Short Interest | 60,835 |
| Short Previous Month | 46,157 |
| Short % of Shares Out | 0.34% |
| Short % of Float | 0.64% |
| Short Ratio (days to cover) | 0.54 |
Income Statement
In the last 12 months, Exagen had revenue of $56.72 million and -$15.51 million in losses. Loss per share was -$0.84.
| Revenue | 56.72M |
| Gross Profit | 33.64M |
| Operating Income | -14.00M |
| Pretax Income | -17.28M |
| Net Income | -15.51M |
| EBITDA | -12.30M |
| EBIT | -14.00M |
| Loss Per Share | -$0.84 |
Full Income StatementBalance Sheet
The company has $11.19 million in cash and $23.56 million in debt, giving a net cash position of -$12.36 million or -$0.69 per share.
| Cash & Cash Equivalents | 11.19M |
| Total Debt | 23.56M |
| Net Cash | -12.36M |
| Net Cash Per Share | -$0.69 |
| Equity (Book Value) | 6.40M |
| Book Value Per Share | 0.36 |
| Working Capital | 18.51M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 59.30%, with operating and profit margins of -24.68% and -27.34%.
| Gross Margin | 59.30% |
| Operating Margin | -24.68% |
| Pretax Margin | -27.32% |
| Profit Margin | -27.34% |
| EBITDA Margin | -21.69% |
| EBIT Margin | -24.68% |
| FCF Margin | n/a |